Condensed Balance Sheets - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 913,420	$ 9,165,179
Marketable securities	2,330,226	4,086,873
Prepaid research and development	112,225	219,817
Deferred offering costs	553,318	147,445
Prepaid expenses and other current assets	280,914	591,734
Total current assets	4,190,103	14,211,048
Equipment and improvements, net	53,667	73,372
Right-of-use asset	133,105	222,227
Total assets	4,376,875	14,506,647
Current liabilities:
Accounts payable	2,529,220	646,767
Lease obligation, current	145,210	150,095
Accrued expenses and other current liabilities	2,161,374	2,259,955
Insurance premium financing payable	71,662	381,784
Total current liabilities	4,907,466	3,438,601
Lease obligation, net of current portion	0	90,124
Total liabilities	4,907,466	3,528,725
Commitments and contingencies (see Note 13)
Stockholders’ equity:
Preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at September 30, 2024 and December 31, 2023	0	0
Common stock, $0.001 par value; 100,000,000 shares authorized; 7,464,070 and 6,186,280 shares issued and outstanding at September 30, 2024 and December 31, 2023	7,464	6,186
Additional paid-in capital	81,748,225	77,871,584
Accumulated other comprehensive income	1,754	877
Accumulated deficit	(82,288,034)	(66,900,725)
Total stockholders' (deficit) equity	(530,591)	10,977,922
Total liabilities and stockholders' equity	$ 4,376,875	$ 14,506,647